4//SEC Filing
Cusack Thomas 4
Accession 0001193125-25-276244
CIK 0000818033other
Filed
Nov 11, 7:00 PM ET
Accepted
Nov 12, 9:20 AM ET
Size
7.1 KB
Accession
0001193125-25-276244
Insider Transaction Report
Form 4
Cusack Thomas
Director
Transactions
- Award
Common Stock
2025-11-08+37,879→ 37,879 total - Award
Stock Option (Right to Buy)
2025-11-08$1.10/sh+227,272$249,999→ 227,272 totalExercise: $1.10Exp: 2035-11-08→ Common Stock (227,272 underlying)
Footnotes (3)
- [F1]The shares were granted as restricted stock units which vest in 16 equal quarterly installments beginning one quarter after the date of grant.
- [F2]Each restricted stock unit represents a contingent right to receive one share of common stock.
- [F3]The stock options vest and become exercisable in 48 equal monthly installments beginning one month after the date of grant.
Documents
Issuer
HERON THERAPEUTICS, INC. /DE/
CIK 0000818033
Entity typeother
Related Parties
1- filerCIK 0002094824
Filing Metadata
- Form type
- 4
- Filed
- Nov 11, 7:00 PM ET
- Accepted
- Nov 12, 9:20 AM ET
- Size
- 7.1 KB